Lucid Diagnostics Files 8-K with Material Agreement

Ticker: LUCD · Form: 8-K · Filed: May 30, 2025 · CIK: 1799011

Sentiment: neutral

Topics: material-agreement, 8-K, filing

TL;DR

Lucid Diagnostics filed an 8-K on 5/30/25 for a material definitive agreement.

AI Summary

On May 30, 2025, Lucid Diagnostics Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 360 Madison Avenue, New York, NY.

Why It Matters

This filing indicates a significant new agreement for Lucid Diagnostics, which could impact its business operations and financial performance.

Risk Assessment

Risk Level: medium — An 8-K filing regarding a material definitive agreement suggests significant business developments that could carry inherent risks and opportunities.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement filed by Lucid Diagnostics Inc. on May 30, 2025?

The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on May 30, 2025.

Where are Lucid Diagnostics Inc.'s principal executive offices located?

Lucid Diagnostics Inc.'s principal executive offices are located at 360 Madison Avenue, 25th Floor, New York, New York 10017.

What is the state of incorporation for Lucid Diagnostics Inc.?

Lucid Diagnostics Inc. is incorporated in Delaware.

What is the SEC file number for Lucid Diagnostics Inc.'s filing?

The SEC file number for Lucid Diagnostics Inc. is 001-40901.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Lucid Diagnostics Inc. (LUCD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing